Early suspicion of disseminated cutaneous mucormycosis leading to successful treatment after bone marrow transplantation in a patient with acute myeloid leukemia
-
- Abematsu Takanari
- Department of Pediatrics, Kagoshima University Hospital
-
- Okamoto Yasuhiro
- Department of Pediatrics, Kagoshima University Hospital
-
- Nakagawa Shunsuke
- Department of Pediatrics, Kagoshima University Hospital
-
- Kurauchi Koichiro
- Department of Pediatrics, Kagoshima University Hospital
-
- Kodama Yuichi
- Department of Pediatrics, Kagoshima University Hospital
-
- Nishikawa Takuro
- Department of Pediatrics, Kagoshima University Hospital
-
- Tanabe Takayuki
- Department of Pediatrics, Kagoshima University Hospital
-
- Shinkoda Yuichi
- Department of Pediatrics, Kagoshima University Hospital
-
- Hatanaka Miho
- Department of Dermatology, Kagoshima University Hospital
-
- Yoshioka Takako
- Department of Pathology, Kagoshima University Hospital
-
- Kawano Yoshifumi
- Department of Pediatrics, Kagoshima University Hospital
Bibliographic Information
- Other Title
-
- 早期の想定が功を奏した急性骨髄性白血病の骨髄移植後に発症した播種性皮膚ムコール感染症例
Search this article
Abstract
<p>Mucormycosis can be life-threatening, especially when the infection is disseminated. Early diagnosis is essential, although a lack of specific biomarkers renders this difficult. We present the case of a patient with acute myeloid leukemia with disseminated cutaneous mucormycosis treated successfully. We initiated liposomal amphotericin B treatment before a definitive diagnosis was made, basing the decision on the presence of multiple risk factors for mucormycosis, such as severe neutropenia and monocytopenia due to bone marrow suppression and exacerbation of the primary disease, malignant hematological disease, bone marrow transplantation, excess iron due to blood transfusion, and precedent initiation of voriconazole. The skin lesions improved without surgical resection. This case illustrates that understanding the risk factors for mucormycosis and prompt administration of appropriate therapy are essential for its treatment in patients with hematological malignancies.</p>
Journal
-
- The Japanese Journal of Pediatric Hematology / Oncology
-
The Japanese Journal of Pediatric Hematology / Oncology 55 (3), 298-303, 2018
The Japanese Society of Pediatric Hematology / Oncology
- Tweet
Keywords
Details
-
- CRID
- 1390001288084463744
-
- NII Article ID
- 130007500957
-
- ISSN
- 21895384
- 2187011X
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed